The overall findings emerging in terms of extracellular activation and diversified signaling in metabolism and cancer for AKT (reviewed in Gonzales and McGraw [39]) will play a key role in further defining their exact involvement in modulating the IR signal during the malignant transition occurring in obese and overtly diabetic patients. This evidence concerns the gene AKT1 and cancer.